SIGA Investor Relations Material
Latest events
Q3 2024
SIGA
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from SIGA Technologies Inc
Access all reports
Segment Data
Access more data
Revenue by
Geography
U.S.
Canada
EMEA
APAC
Other
Expenses by
Financials
SIGA Technologies, Inc. is a pharmaceutical company focused on the development and commercialization of countermeasures to address infectious diseases and biological threats. The company specializes in antiviral therapies, with a particular emphasis on treatments for diseases caused by orthopoxviruses, including smallpox. SIGA’s products are primarily used by government agencies and health organizations to strengthen preparedness for potential outbreaks or bioterrorism events. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
SIGA
Country
🇺🇸 United States